Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors

BACKGROUND: The use of baseline tumor burden (TB) as a prognostic factor for non‐small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) and associations between TB and other prognostic biomarkers remain unclear. In this study, we investigated the association between...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Sakata, Yoshihiko, Kawamura, Kodai, Ichikado, Kazuya, Shingu, Naoki, Yasuda, Yuko, Eguchi, Yoshitomo, Hisanaga, Jumpei, Nitawaki, Tatsuya, Iio, Miwa, Sekido, Yuko, Nakano, Aiko, Sakagami, Takuro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885438/
https://ncbi.nlm.nih.gov/pubmed/31679185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13214
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados